For the past 40 years, demonstration of benefit with a temporarily implanted neuromodulation device generally has been required before implantation of a permanent system. Ongoing clinical experience, new studies and new technical developments are calling this into question.
Upon completion of this educational activity, participants should be able to:
- Discuss the historical background, design, and interpretation of trials and their outcomes, including benefits and risks.
- Identify ongoing and recent studies.
- Describe recent technical developments such as wireless "perm trials"
- Explain health economic implications.
Simon J. Thomson, MBBS FRCA FIPP FFPMRCA
Recent Studies (TRIAL-STIM. RCT)
Sam S. Eldabe, MB ChB FRCA FFPMRCA
Recent Technical Developments
Konstantin V. Slavin, MD
Health Economic Implications
Rui Duarte, PhD MSc
Faculty and Presentations subject to change.
- Thematic Abstract Presentations
- Plenary Session I -- What We Have Learned About Placebo: Implications for Clinical Practice and the Interpretation of Evidence About Analgesics
- Plenary Session II -- When It's Time to Say No: Patient Selection
- Emerging Indications for Deep Brain Stimulation
- Practice Development